INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
08/12/2026
Back to search
Official data from USPTO
SAWAI
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
35
Latest update
08/12/2026
Trademark type
Combined
Nice classes
1, 5, 16
Filing date
09/28/2017
Registration date
05/28/2019
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/12/2025
Last transaction
08/12/2026
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
3
Owner type
03
Owner location
JP
Examiner
PEREZ, STEVEN M
Law office
L10
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the word "SAWAI" in stylized font above an upward curving line.
Holders and representatives
Holders
SAWAI PHARMACEUTICAL Co., Ltd.
Representatives
Shauna M. Wertheim The Marbury Law Group, PLLC
Technical classification
Nice Classes
Class 1Class 5Class 16
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemicals and chemical preparations for use in the manufacture of pharmaceuticals
Class 5
Pharmaceutical preparations for medical or veterinary purposes for the prevention and treatment of disorders or diseases of the central nervous systemthe peripheral nervous systemthe musculo-skeletal systemthe cardiovascular systemthe respiratory systemthe gastrointestinal systemthe genitourinary systemthe endocrine systemthe metabolic systemthe immune systemthe psychological system; pharmaceutical preparations for medical or veterinary purposes for use in dermatologyoncologyophthalmologythe treatment of allergiesthe treatment of infectionsthe treatment of circulatory system diseasesthe treatment of diabetesthe treatment of hyperlipidemiathe treatment of osteoporosis; pharmaceutical preparations in the nature of vitamins and vitamin preparations for medical or veterinary purposes; diagnostic pharmaceutical preparations for medical or veterinary purposes; pharmaceutical preparations and substances for the treatment of viralmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinarysexual dysfunctiononcologicalhepatologicalophthalmicrespiratoryneurologicalgastrointestinalhormonaldermatologicalpsychiatric and immune system related diseases and disorders
Class 16
Banners of paper; paper bunting; hygienic hand towels of paper; towels of paper; table napkins of paper; hand towels of paper; handkerchiefs of paper; paper and cardboard; stationery; printed matterbusiness cards and integrated reports featuring information regarding pharmaceutical clinical trials; printed photographs; photograph stands
Publications
History of USPTO decisions and trademark events.
35 publications found
C71T
CANCELLED SECTION 71
12/12/2025
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
05/28/2024
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
10/04/2019
FICS
FINAL DISPOSITION NOTICE SENT TO IB
09/13/2019
FIMP
FINAL DISPOSITION PROCESSED
09/13/2019
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
08/28/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
05/28/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/12/2019
PUBO
PUBLISHED FOR OPPOSITION
03/12/2019
GPNX
NOTIFICATION PROCESSED BY IB
03/08/2019
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
02/20/2019
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
02/20/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/20/2019
ALIE
ASSIGNED TO LIE
02/01/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/17/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/17/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/17/2019
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
01/17/2019
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
10/16/2018
GNFR
FINAL REFUSAL E-MAILED
10/16/2018
CNFR
FINAL REFUSAL WRITTEN
10/16/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/04/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/04/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/04/2018
RFNT
REFUSAL PROCESSED BY IB
03/30/2018
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
03/14/2018
RFRR
REFUSAL PROCESSED BY MPU
03/14/2018
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
03/08/2018
CNRT
NON-FINAL ACTION WRITTEN
03/07/2018
MAFR
APPLICATION FILING RECEIPT MAILED
03/03/2018
DOCK
ASSIGNED TO EXAMINER
02/27/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/27/2018
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
02/20/2018
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
02/15/2018
Continuous trademark protection
Get notified about every new filing that threatens SAWAI or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.